tiprankstipranks
Trending News
More News >
Revvity, Inc. (RVTY)
:RVTY
US Market
Advertisement

Revvity (RVTY) Earnings Dates, Call Summary & Reports

Compare
543 Followers

Earnings Data

Report Date
Jan 29, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.54
Last Year’s EPS
1.42
Same Quarter Last Year
Moderate Buy
Based on 11 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 27, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
Revvity reported strong performance in software and reproductive health segments, with notable achievements in AI innovations and strategic partnerships. However, challenges in China and overall low organic growth present concerns.
Company Guidance
In the Q3 2025 earnings call, Revvity provided an updated outlook, emphasizing a 2% to 4% organic growth expectation for the year and raising the adjusted earnings per share guidance to $4.9 to $5. Despite a challenging market environment, the company reported 1% organic growth, with notable contributions from the signals software business growing 20% organically, and reproductive health expanding in the mid-single digits. Revvity achieved a 26.1% adjusted operating margin, slightly exceeding expectations, and generated $120 million in free cash flow. The company's disciplined capital deployment included a $205 million share repurchase, part of a new $1 billion authorization. Looking ahead to 2026, Revvity anticipates 2% to 3% organic growth with a 28% adjusted operating margin baseline, driven by restructuring activities and strategic partnerships, including collaborations with Genomics England and Sanofi. The company remains optimistic about AI-driven innovations and improving market conditions.
Strong Performance in Signals Software Business
The Signals Software business grew 20% organically in the quarter with even stronger SaaS performance and conversion. ARR over 40%, APV 12%, and net retention rate more than 110%.
Reproductive Health Business Growth
The reproductive health business grew in the mid-single digits year over year with newborn screening growing in the high single digits.
Adjusted Operating Margins and EPS
Generated 26.1% adjusted operating margins, modestly above expectations, and adjusted earnings per share of $1.18, which was $0.05 above the midpoint of guidance.
Capital Deployment and Share Repurchase
Strong focus on cash flow generation with $120 million free cash flow and $205 million spent repurchasing 2.3 million shares. New $1 billion share repurchase authorization received.
AI-Driven Innovations
Launch of new AI-focused software offerings and partnerships, including SignalsOne, Transcribe AI, and Phenologic AI, with continued robust development pipeline.
Strategic Partnerships
Collaborations with Genomics England and Sanofi to develop assays for early screening and improving diagnostics capabilities.
Environmental and Social Responsibility Achievements
6% reduction in emissions, 47% waste diversion, and 77% employee satisfaction rate. Received a triple-A rating from MSCI for ESG efforts.

Revvity (RVTY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RVTY Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 29, 2026
2025 (Q4)
1.54 / -
1.42
Oct 27, 2025
2025 (Q3)
1.14 / 1.18
1.28-7.81% (-0.10)
Jun 29, 2025
2025 (Q2)
1.15 / 1.18
1.22-3.28% (-0.04)
Apr 28, 2025
2025 (Q1)
0.95 / 1.01
0.983.06% (+0.03)
Jan 31, 2025
2024 (Q4)
1.37 / 1.42
1.2513.60% (+0.17)
Nov 04, 2024
2024 (Q3)
1.13 / 1.28
1.188.47% (+0.10)
Jul 29, 2024
2024 (Q2)
1.12 / 1.22
1.210.83% (+0.01)
Apr 29, 2024
2024 (Q1)
0.94 / 0.98
1.01-2.97% (-0.03)
Feb 01, 2024
2023 (Q4)
1.17 / 1.25
1.7-26.47% (-0.45)
Oct 30, 2023
2023 (Q3)
1.19 / 1.18
1.51-21.85% (-0.33)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

RVTY Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 27, 2025
$98.89$97.16-1.75%
Apr 28, 2025
$94.15$94.92+0.82%
Jan 31, 2025
$126.56$125.85-0.56%
Nov 04, 2024
$120.70$124.47+3.12%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Revvity, Inc. (RVTY) report earnings?
Revvity, Inc. (RVTY) is schdueled to report earning on Jan 29, 2026, After Close (Confirmed).
    What is Revvity, Inc. (RVTY) earnings time?
    Revvity, Inc. (RVTY) earnings time is at Jan 29, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RVTY EPS forecast?
          RVTY EPS forecast for the fiscal quarter 2025 (Q4) is 1.54.

            Revvity (RVTY) Earnings News

            Revvity (NYSE:RVTY) Tanks on Q3 Miss
            Premium
            Market News
            Revvity (NYSE:RVTY) Tanks on Q3 Miss
            2y ago
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis